For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

noninvasive method that provides information about the distribution and extent of amyloid deposit throughout the body. This is a highly conserved invariant plasma glycoprotein that, as a result of ...

A recent study has revealed a surprising connection between a seemingly harmless habit—nose picking—and the potential risk of ...

Microglia can partially break down amyloid plaques by "spitting" a digestive enzyme at them, a new study has found.

ProMIS Neurosciences (PMN) announced the initiation of its Phase 1b clinical trial evaluating its lead therapeutic candidate, PMN310, in ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Targeting toxic oligomers without binding to plaque, designed to reduce the risk of ARIA and potentially deliver enhanced ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

A study published in 2022 revealed a tenuous but plausible link between picking your nose and increasing the risk of ...

ATTR is characterised by the formation of amyloid fibril deposits in tissues and organs – in the heart in the case of patients with cardiomyopathy. NI006 is an antibody that binds to the ...

Learn all about various types of certificates of deposit, how they work and how they potentially fit into your savings and investment planning. Browse Investopedia’s expert-written library to ...

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...